Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 4, 2025 · Filed Nov 6, 2025
A Calix director sold $784K of Calix shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$783,584
Shares × reported transaction price
6 days after results of Oct 29, 2025, 85 days before results of Jan 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −8.3% | +0.1% | −8.5% |
| 30 days | −14.3% | +1.9% | −16.2% |
| 90 days | −20.9% | +1.0% | −21.9% |
| 180 days | −30.8% | +9.4% | −40.1% |
Past results only. Not a forecast.
Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 24, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 17, 2025 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.